Status:
UNKNOWN
Oral Pregabalin Premedication for Postoperative Pain Relief
Lead Sponsor:
Zagazig University
Conditions:
Gynecologic Disease
Eligibility:
FEMALE
21-60 years
Phase:
NA
Brief Summary
Pain management after gynecological surgeries is essential for early mobilization of the patient, decrease postoperative complication and hospital stay. The use of opioids is associated with adverse e...
Detailed Description
Postoperative pain, nausea and vomiting continue to be one of the most common and unpleasant complications after surgery. The traditional pain treatment with opioids alone is not adequate any more. To...
Eligibility Criteria
Inclusion
- Physical status: ASA I-II
- BMI ≥ 20kg/m2 \& ≤ 35kg/m2,
- Written informed consent from the patient.
Exclusion
- Patients with known history of allergy to study drugs,
- Patients on ACE inhibitors, anticonvulsant therapy or any drug interacting with pregabalin,
- Patients on chronic alcohol, opioid, tranquilizer or sedative use,
- Patient with renal impairment or heart failure,
- Pregnant females, Psychological, mental disorders or depression,
- Patients receiving anticoagulants therapy or suspected coagulopathy,
- Patients already on pregbalin or gabapentin therapy.
Key Trial Info
Start Date :
August 20 2020
Trial Type :
INTERVENTIONAL
Allocation :
ESTIMATED
End Date :
November 1 2021
Estimated Enrollment :
90 Patients enrolled
Trial Details
Trial ID
NCT04708353
Start Date
August 20 2020
End Date
November 1 2021
Last Update
September 5 2021
Active Locations (1)
Enter a location and click search to find clinical trials sorted by distance.
1
faculty of medicine, Zagazig university
Zagazig, Elsharqya, Egypt, 44519